Thyroid abnormalities following the use of cytotoxic T‐lymphocyte antigen‐4 and programmed death receptor protein‐1 inhibitors in the treatment of melanoma
D.L. Morganstein; Z. Lai; L. Spain; S. Diem; D. Levine; C. Mace; M. Gore; J. Larkin
Author Information: Skin Unit
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.